logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/09/2025
Airbus: As of October 2025, the first batch will have up to a maximum of 2.07 million shares; the maximum number of shares involved in this transaction can reach up to 4.14 million shares.
Latest
2 m ago
Market 100% betting on the Fed restarting rate cuts in September, probability of a 50 basis point cut increasing
3 m ago
Institutional investors rational view on the A-share structure switch, anchoring investment in economic recovery and transformation.
4 m ago
The performance of the US consumer sector is under pressure, as the ongoing uncertainty of tariffs continues to impact business profits and consumer behavior.
5 m ago
Kaituo Pharmaceuticals -B (09939.HK): KT-939 human long-term safety trial has completed all subjects enrollment.
12 m ago
The North Exchange conducts multiple rounds of progressive inquiries into companies planning to go public, rigorously examining the "gold content" of their performance and the feasibility of their fundraising projects.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.